13D/13G Filings - BIOTECHNOLOGY VALUE FUND L P

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, 4, 5, ...17, 18, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-11-14
4:24 pm
Purchase
2024-09-30 13G Cullinan Oncology, Inc.
CGEM
BIOTECHNOLOGY VALUE FUND L P 5,796,433
9.990%
1,403,112increase
(+31.94%)
Filing
History
2024-11-14
4:24 pm
Sale
2024-09-30 13G Janux Therapeutics, Inc.
JANX
BIOTECHNOLOGY VALUE FUND L P 0
0.000%
-4,579,818decrease
(Position Closed)
Filing
History
2024-11-14
4:23 pm
Sale
2024-09-30 13G IDEAYA Biosciences, Inc.
IDYA
BIOTECHNOLOGY VALUE FUND L P 1,409,993
1.700%
-2,069,050decrease
(-59.47%)
Filing
History
2024-11-14
4:22 pm
Purchase
2024-09-30 13G Cidara Therapeutics, Inc.
CDTX
BIOTECHNOLOGY VALUE FUND L P 703,126
9.990%
703,126increase
(New Position)
Filing
History
2024-11-14
4:21 pm
Sale
2024-09-30 13G Delcath Systems, Inc.
DCTH
BIOTECHNOLOGY VALUE FUND L P 1,041,667
3.600%
-1,296,759decrease
(-55.45%)
Filing
History
2024-11-14
4:20 pm
Sale
2024-09-30 13G Centessa Pharmaceuticals plc
CNTA
BIOTECHNOLOGY VALUE FUND L P 0
0.000%
-8,774,570decrease
(Position Closed)
Filing
History
2024-11-13
4:08 pm
Purchase
2024-09-30 13G 4D Molecular Therapeutics, Inc.
FDMT
BIOTECHNOLOGY VALUE FUND L P 7,382,642
14.200%
3,375,229increase
(+84.22%)
Filing
History
2024-11-12
5:27 pm
Sale
2024-11-07 13G Third Harmonic Bio, Inc.
THRD
BIOTECHNOLOGY VALUE FUND L P 2,372,933
5.300%
-1,993,000decrease
(-45.65%)
Filing
History
2024-11-01
4:27 pm
Purchase
2024-10-25 13G Septerna, Inc.
SEPN
BIOTECHNOLOGY VALUE FUND L P 2,452,024
5.500%
2,452,024increase
(New Position)
Filing
History
2024-10-31
5:50 pm
Unchanged
2024-10-29 13G Eledon Pharmaceuticals, Inc.
ELDN
BIOTECHNOLOGY VALUE FUND L P 6,293,282
10.500%
0
(Unchanged)
Filing
History
2024-10-31
5:49 pm
Purchase
2024-09-30 13G Eledon Pharmaceuticals, Inc.
ELDN
BIOTECHNOLOGY VALUE FUND L P 6,293,282
15.900%
1,966,572increase
(+45.45%)
Filing
History
2024-10-29
4:32 pm
Purchase
2024-10-25 13D Molecular Partners AG
MOLN
BIOTECHNOLOGY VALUE FUND L P 9,888,592
24.500%
1,192,387increase
(+13.71%)
Filing
History
2024-10-21
9:00 pm
Unchanged
2024-10-17 13D Inventiva S.A.
IVA
BIOTECHNOLOGY VALUE FUND L P 8,545,499
9.800%
0
(Unchanged)
Filing
History
2024-10-08
6:48 pm
Sale
2024-10-04 13D MoonLake Immunotherapeutics
MLTX
BIOTECHNOLOGY VALUE FUND L P 19,751,284
31.400%
-2,000,000decrease
(-9.19%)
Filing
History
2024-09-11
7:42 pm
Sale
2024-09-02 13G Calliditas Therapeutics AB (publ)
CALT
BIOTECHNOLOGY VALUE FUND L P 0
0.000%
-6,260,311decrease
(Position Closed)
Filing
History
2024-08-23
4:34 pm
Purchase
2024-08-13 13G Avalo Therapeutics, Inc.
AVTX
BIOTECHNOLOGY VALUE FUND L P 967,299
9.990%
967,299increase
(New Position)
Filing
History
2024-08-19
6:48 pm
Purchase
2024-08-08 13G Tenax Therapeutics, Inc.
TENX
BIOTECHNOLOGY VALUE FUND L P 340,660
9.990%
340,660increase
(New Position)
Filing
History
2024-07-19
4:30 pm
Unchanged
2024-07-17 13D Inventiva S.A.
IVA
BIOTECHNOLOGY VALUE FUND L P 8,545,499
16.300%
0
(Unchanged)
Filing
History
2024-06-10
5:01 pm
Purchase
2024-05-30 13G Celcuity Inc.
CELC
BIOTECHNOLOGY VALUE FUND L P 3,466,000
9.900%
3,466,000increase
(New Position)
Filing
History
2024-05-30
4:51 pm
Purchase
2024-05-20 13G Foghorn Therapeutics Inc.
FHTX
BIOTECHNOLOGY VALUE FUND L P 5,552,341
9.990%
5,552,341increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2, 3, 4, 5, ...17, 18, Next